Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Julie Chas

Datos Biográficos

ID7450283
NOMBREJulie Chas
NOMBRESJulie
APELLIDOChas
FIRMACHAS J
AFILIACIONESSorbonne Université
ORCID0000-0002-1001-9229
VERIFICADOSí
TOTAL DE OBRAS7
TOTAL DE CITAS0
TOTAL COMO AUTOR7
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2015
AÑO MÁS RECIENTE DE PUBLICACIÓN2021
ÍNDICE H0
  • HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 Hepavih Cohort Study)

    Open Access•Tangui Barré, Patrick Mercié et al.•ARTICLE•AIDS and Behavior•2021

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER)

    Open Access•Alec Rodger, Alison J Rodger et al.•ARTICLE•The Lancet•2019

    BACKGROUND: The level of evidence for HIV transmission risk through condomless sex in serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral therapy (ART) is limited compared with the evidence available for transmission risk in heterosexual couples. The aim of the second phase of the PARTNER study (PARTNER2) was to provide precise estimates of transmission risk in gay serodifferent partnerships. METHODS:…

  • The ANRS-Ipergay trial, an opportunity to use qualitative research to understand the perception of the “participant”-physician relationship

    Marion Di Ciaccio, Christel Protière et al.•ARTICLE•AIDS Care•2018

    The ANRS-IPERGAY trial consisted in providing sexual activity-based antiretroviral prophylaxis for HIV prevention (PrEP) with a package of prevention tools (counselling, condoms, HIV and sexually transmitted infections' screening) to highly exposed HIV-negative men who have sex with men (MSM). Few data exist concerning the patient-physician relationship in the particular context of PrEP, where physicians discuss sexual behaviours with MSM who are…

  • Response to the Hammoud et al paper on ‘the new MTV generation’

    Open Access•Mitzy Gafos, Julie Chas et al.•ARTICLE•International Journal of Drug…•2018

  • Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men

    Open Access•Jean‐michel Molina, Jean-Michel Molina et al.•ARTICLE•The Lancet HIV•2017

  • Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS Ipergay trial

    Open Access•Luis Sagaon-Teyssier, Marie Suzan-Monti et al.•ARTICLE•AIDS Care•2016

    The double-blind phase of the randomized ANRS IPERGAY trial, evaluating sexual activity-based oral HIV pre-exposure prophylaxis (PrEP), was conducted among high-risk men who have sex with men (MSM). Results showed an 86% (95% CI: 40-98) relative reduction in HIV incidence among participants with tenofovir disoproxil fumarate-emtricitabine vs. placebo. The present pooled analysis aimed to analyze (i) participants' adherence to the prescribed treat…

  • On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

    Jean‐michel Molina, Jean-Michel Molina et al.•ARTICLE•New England Journal of Medicine•2015

    BACKGROUND: Antiretroviral preexposure prophylaxis has been shown to reduce the risk of human immunodeficiency virus type 1 (HIV-1) infection in some studies, but conflicting results have been reported among studies, probably due to challenges of adherence to a daily regimen. METHODS: We conducted a double-blind, randomized trial of antiretroviral therapy for preexposure HIV-1 prophylaxis among men who have unprotected anal sex with men. Particip…

Sin obras prominentes en esta página.

  • On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

    Jean‐michel Molina, Jean-Michel Molina et al.•ARTICLE•New England Journal of Medicine•2015

    BACKGROUND: Antiretroviral preexposure prophylaxis has been shown to reduce the risk of human immunodeficiency virus type 1 (HIV-1) infection in some studies, but conflicting results have been reported among studies, probably due to challenges of adherence to a daily regimen. METHODS: We conducted a double-blind, randomized trial of antiretroviral therapy for preexposure HIV-1 prophylaxis among men who have unprotected anal sex with men. Particip…

  • Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS Ipergay trial

    Open Access•Luis Sagaon-Teyssier, Marie Suzan-Monti et al.•ARTICLE•AIDS Care•2016

    The double-blind phase of the randomized ANRS IPERGAY trial, evaluating sexual activity-based oral HIV pre-exposure prophylaxis (PrEP), was conducted among high-risk men who have sex with men (MSM). Results showed an 86% (95% CI: 40-98) relative reduction in HIV incidence among participants with tenofovir disoproxil fumarate-emtricitabine vs. placebo. The present pooled analysis aimed to analyze (i) participants' adherence to the prescribed treat…

  • Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men

    Open Access•Jean‐michel Molina, Jean-Michel Molina et al.•ARTICLE•The Lancet HIV•2017

  • The ANRS-Ipergay trial, an opportunity to use qualitative research to understand the perception of the “participant”-physician relationship

    Marion Di Ciaccio, Christel Protière et al.•ARTICLE•AIDS Care•2018

    The ANRS-IPERGAY trial consisted in providing sexual activity-based antiretroviral prophylaxis for HIV prevention (PrEP) with a package of prevention tools (counselling, condoms, HIV and sexually transmitted infections' screening) to highly exposed HIV-negative men who have sex with men (MSM). Few data exist concerning the patient-physician relationship in the particular context of PrEP, where physicians discuss sexual behaviours with MSM who are…

  • Response to the Hammoud et al paper on ‘the new MTV generation’

    Open Access•Mitzy Gafos, Julie Chas et al.•ARTICLE•International Journal of Drug…•2018

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER)

    Open Access•Alec Rodger, Alison J Rodger et al.•ARTICLE•The Lancet•2019

    BACKGROUND: The level of evidence for HIV transmission risk through condomless sex in serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral therapy (ART) is limited compared with the evidence available for transmission risk in heterosexual couples. The aim of the second phase of the PARTNER study (PARTNER2) was to provide precise estimates of transmission risk in gay serodifferent partnerships. METHODS:…

  • HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 Hepavih Cohort Study)

    Open Access•Tangui Barré, Patrick Mercié et al.•ARTICLE•AIDS and Behavior•2021

Medicine (7 obras) · HIV/AIDS Research and Interventions (6 obras) · Family medicine (5 obras) · Men who have sex with men (5 obras) · Pre-exposure prophylaxis (4 obras) · Demography (3 obras) · HIV, Drug Use, Sexual Risk (3 obras) · HIV/AIDS drug development and treatment (3 obras) · Human immunodeficiency virus (HIV) (3 obras) · Internal Medicine (3 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae